Are GLP1 side effects all the same?

Do some GLP1s have less negative side effects? They work the same, but can affect you differently -- let's look at the research.

Are GLP1 side effects all the same?
Question Mark

There are many different formulations of GLP1 Receptor Agonists:

  • Semaglutide (Ozempic, Wegovy, Rybelsus)
  • Tirzepatide (Mounjaro, Zepbound)
  • Dulaglutide (Trulicity)
  • Liraglutide (Victoza, Saxenda)
  • Exenatide (Byetta)

After much research, we know that they work the same way in general, but do they have different negative side effects?

🍃
Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic, Mounjaro, Wegovy, or Zepbound work?

Check out our quick explainer

What are the known negative side effects to expect?

We don't know everything that can go wrong when someone takes a GLP1 Receptor Agonist (whether for weight loss or type 2 diabetes), but after decades of research, we've learned some things.

  • Some of the most common side effects
    • Low blood sugar (common for people with type 2 Diabetes)
    • Upset Stomach and related symptoms (gas, heartburn, bloating)
    • Nausea
    • Vomiting
    • Stomach pain
    • Headache
    • Dizziness
    • Tiredness
    • Upset Stomach
  • Some less common but more serious side effects
    • Gastroparesis
    • Pancreatitis
    • Thyroid issues

Want to learn about the side effects in more depth? We've written a bit you might want to read:

Do GLP1 RA drugs damage the gut?
The most common negative side effects of taking GLP1 Receptor Agonist drugs are gut related. Luckily for us, with the widespread availability and interest in GLP1 RA drugs like Ozempic, Mounjaroy, Wegovy and others, there is much research to read on the likelihood of these risks. In the research these
Are GLP1 drugs (Semaglutide) safe?
Drugs like Ozempic, Mounjaro, Wegovy and others are helping people beat type 2 Diabetes and lose weight, but are these drugs safe? 💡Don’t know what “GLP1” means? Check out our explainer article on “GLP1 Agonists” for an easy to understand explanation. What does “safe” mean? Before we can talk about

That said, it turns out some formulations of GLP1 have less side effects than others. It's more like a lower likelihood of the same side effects, but let's see which ones.

But which GLP1s have less side effects?


Thankfully there's been some published research into this issue:

Research paper (source: https://www.mdpi.com/1424-8247/17/2/199)

The analysis covers a large range of patients, with a helpful graph of the organizational method:

Pharmaceuticals 17 00199 g001
Organizational method of the study

There's also a helpful graph of the data:

Pharmaceuticals 17 00199 g002
Graph of adverse effects from the study

Thanks to this study, we can take a way a little information

  • Dulaglutide: Higher rates of abdominal pain, constipation, diarrhea, and nausea and vomiting compared to semaglutide.
  • Liraglutide: Highest incidence of pancreatitis (4.0%) and higher odds of abdominal pain, nausea and vomiting, and gastroparesis compared to semaglutide.
  • Semaglutide: Lower rates of abdominal pain, constipation, diarrhea, and nausea and vomiting compared to dulaglutide and liraglutide.
  • Exenatide: Lower rates of gastrointestinal adverse events compared to dulaglutide and liraglutide, and appeared safer overall except for gastroparesis.
⚠️
While the study was useful, it's results are not gospel! More work has to be done in intentionally comparing adverse effects of GLP1 Receptor Agonists, and over larger groups to collect more data and be able to make more concrete deductions.

More research is still needed, and the researchers call out that need themselves.

So which GLP1 should you take?

The short answer is to ask your doctor, and work with them as you figure out what works and doesn't work.

While the study was pretty lenient on Exenatide, it's important to know that your body is different, and could have infinitely many reasons that one drug might work better or worse for you (or possibly no GLP1s may be compatible at all!).